J Menopausal Med.  2018 Aug;24(2):75-80. 10.6118/jmm.2018.24.2.75.

Klotho and Postmenopausal Hormone Replacement Therapy in Women with Chronic Kidney Disease

• Park YJ
• Kim JM

• KMID: 2419614
• DOI: http://doi.org/10.6118/jmm.2018.24.2.75

Abstract

Kidney function is highly susceptible to age-related changes, with chronic kidney disease (CKD) serving as an important cause of morbidity and mortality in older patients. The prevalence of CKD in Korea is higher among the elderly, relative to the general population, with the most significant increases seen following the onset of menopause. Under normal conditions, estrogen attenuates renal superoxide production and protects the kidney from oxidative damage. As estrogen levels are known to decrease by as much as 80% during menopause, this represents a significant risk for older women. Postmenopausal hormone replacement therapy (HRT) modulates the renin-angiotensin system, thereby reducing the progressive deterioration of renal function. Use of estrogen-based HRT has been shown to ameliorate renal function in postmenopausal women, and delay CKD progression. Renal expression of klotho, an important suppressor of aging, is markedly decreased in CKD patients, making it a promising candidate for use as a prognostic biomarker in CKD. Here, we review the key links between renal function, sex, age, and estrogen levels during menopause, and discuss the use of postmenopausal HRT in CKD attenuation.

Keyword

Estrogen replacement therapy; Hormone replacement therapy; Postmenopause; Renal insufficiency, chronic

MeSH Terms

Aged
Aging
Estrogen Replacement Therapy*
Estrogens
Female
Hormone Replacement Therapy
Humans
Kidney
Korea
Menopause
Mortality
Postmenopause
Prevalence
Renal Insufficiency, Chronic*
Renin-Angiotensin System
Superoxides
Estrogens
Superoxides

Reference

1. Park JI, Baek H, Jung HH. Prevalence of chronic kidney disease in Korea: the Korean national health and nutritional examination survey 2011-2013. J Korean Med Sci. 2016; 31:915–923.

2. Yu M, Ryu DR, Kim SJ, Choi KB, Kang DH. Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey. Nephrol Dial Transplant. 2010; 25:469–477.

3. Ahmed SB, Ramesh S. Sex hormones in women with kidney disease. Nephrol Dial Transplant. 2016; 31:1787–1795.

4. Mencke R, Olauson H, Hillebrands JL. Effects of Klotho on fibrosis and cancer: a renal focus on mechanisms and therapeutic strategies. Adv Drug Deliv Rev. 2017; 121:85–100.

5. Kim S, Lim CS, Han DC, Kim GS, Chin HJ, Kim SJ, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci. 2009; 24:Suppl. S11–S21.

6. Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis. 2013; 62:339–351.

7. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010; 17:302–307.

8. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950; 29:496–507.

9. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976; 31:155–163.

10. Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abrams HL, Merrill JP. Senescence and the renal vasculature in normal man. Circ Res. 1974; 34:309–316.

11. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988; 67:876–881.

12. Lips P, Goldsmith D, de Jongh R. Vitamin D and osteoporosis in chronic kidney disease. J Nephrol. 2017; 30:671–675.

13. Yun BH, Chon SJ, Cho SH, Choi YS, Lee BS, Seo SK. Decreased renal function is a risk factor for subclinical coronary atherosclerosis in Korean postmenopausal women. J Menopausal Med. 2016; 22:167–173.

14. Gipson D, Katz LA, Stehman-Breen C. Principles of dialysis: special issues in women. Semin Nephrol. 1999; 19:140–147.

15. Weisinger JR, Bellorin-Font E. Outcomes associated with hypogonadism in women with chronic kidney disease. Adv Chronic Kidney Dis. 2004; 11:361–370.

16. Cobo G, Hecking M, Port FK, Exner I, Lindholm B, Stenvinkel P, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci (Lond). 2016; 130:1147–1163.

17. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000; 11:319–329.

18. Luksha L, Stenvinkel P, Hammarqvist F, Carrero JJ, Davidge ST, Kublickiene K. Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease. PLoS One. 2012; 7:e36056.

19. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 2000; 58:1261–1266.

20. Schmidt RJ, Yokota S, Tracy TS, Sorkin MI, Baylis C. Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis. Am J Physiol. 1999; 276:F794–F797.

21. Ji H, Pesce C, Zheng W, Kim J, Zhang Y, Menini S, et al. Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am J Physiol Heart Circ Physiol. 2005; 288:H43–H47.

22. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension. 1998; 32:730–734.

23. Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol. 1997; 8:1240–1246.

24. Xiao S, Gillespie DG, Baylis C, Jackson EK, Dubey RK. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension. 2001; 37:645–650.

25. Ji H, Zheng W, Menini S, Pesce C, Kim J, Wu X, et al. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med. 2007; 4:56–71.

26. Cohen AM, Rosenmann E. Male sex hormone and nephropathy in Cohen diabetic rat. (Genetically selected sucrose fed). Diabete Metab. 1984; 10:199–205.

27. Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med. 1980; 93:21–27.

28. Ramesh S, James MT, Holroyd-Leduc JM, Wilton SB, Seely EW, Wheeler DC, et al. Sex hormone status in women with chronic kidney disease: survey of nephrologists' and renal allied health care providers' perceptions. Can J Kidney Health Dis. 2017; 4:2054358117734534.

29. Kim JM, Kim TH, Lee HH, Lee SH, Wang T. Postmenopausal hypertension and sodium sensitivity. J Menopausal Med. 2014; 20:1–6.

30. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med. 2001; 161:2000–2005.

31. Schopick EL, Fisher ND, Lin J, Forman JP, Curhan GC. Post-menopausal hormone use and albuminuria. Nephrol Dial Transplant. 2009; 24:3739–3744.

32. Fung MM, Poddar S, Bettencourt R, Jassal SK, Barrett-Connor E. A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study. Menopause. 2011; 18:629–637.

33. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011; 22:124–136.

34. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001; 280:1015–1020.

35. Hu MC, Kuro-o M, Moe OW. Klotho and chronic kidney disease. Contrib Nephrol. 2013; 180:47–63.

36. Lim JH, Kim EN, Kim MY, Chung S, Shin SJ, Kim HW, et al. Age-associated molecular changes in the kidney in aged mice. Oxid Med Cell Longev. 2012; 2012:171383.

37. Hsu SC, Huang SM, Lin SH, Ka SM, Chen A, Shih MF, et al. Testosterone increases renal anti-aging klotho gene expression via the androgen receptor-mediated pathway. Biochem J. 2014; 464:221–229.

38. Oz OK, Hajibeigi A, Howard K, Cummins CL, van Abel M, Bindels RJ, et al. Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice*. J Bone Miner Res. 2007; 22:1893–1902.